Vision and Mission
TULEX has a state-of-the art cGMP facility that integrates research and development to manufacture and commercialize their products.
Our leading regenerative medicine product, TWB-103, is a therapeutic cell product for wound care with proven safety and efficacy. Additionally, the product has been designed to provide ease of storage, transportation and bedside use in a cost-effective manner.
With 18 years of proven track record and excellent reputation in the medical device industry, we provide the most competitive price and top quality products to Europe and US markets.
2016 BioTaiwan Exhibition, conferences & partnering. Date: July 20 - 24, 2016